📋 About: Creso Pharma (ASX: CPH) is Medical cannabis and psychedelics company, developing therapeutic, nutraceutical and lifestyle products for human and animal health.

🌏 Macro Theme: World regulations are expected to open up as cannabis and psychedlics become an accepted form of alternative medicine.

Creso Pharma Company Milestones

✅ $9M Cap Raise @ 2.9c: Next Investors Commentary
✅ Convertible Notes Extinguished: Next Investors Commentary
✅ Key Appointment: Bruce Linton: Next Investors Commentary
✅ Next Investors Watchlist: Next Investors Commentary
🌏 TGA Reclassifies Cannabis as a Schedule 4 drug: Next Investors Commentary
🌏 MORE Act Passed in the US: Next Investors Commentary
✅ $18M Cap Raise @19c per share: Next Investors Commentary
🌏 MindMed NASDAQ Listing: Next Investors Commentary 1, Next Investors Commentary 2
✅ OTC Listing
🔲 Improved Global Regulatory Environment for Cannabis
🔲 Improved Global Regulatory Environment for Psychedelics
🔲 Unexpected Positive Announcement 1
🔲 Unexpected Positive Announcement 2
🔲 Unexpected Positive Announcement 3
🔲 Next Investors Portfolio Launch?

Cannabis Products

Purchase orders listed here are over $150k only

✅ Purchase Order 1 $295K (Nutraceutical / Pharma Products)
✅ Purchase Order(s) 2 $415K + (Nutraceutical / Pharma Products): Next Investors Commentary
✅ Purchase Order 3 $300K + (Nutraceutical / Pharma Products)
✅ Purchase Order 4 $247K + (Nutraceutical / Pharma Products): Next Investors Commentary
🔲 Purchase Order 5 (Nutraceutical / Pharma Products)
🔲 Purchase Order 6 (Nutraceutical / Pharma Products)
🔲 Purchase Order 7 (Nutraceutical / Pharma Products)
🔲 Purchase Order 8 (Nutraceutical / Pharma Products)
✅ Purchase Order 1 $242K+ (Mernova Cannabis)
✅ Purchase Order(s) 2 $502K+ (Mernova Cannabis): Next Investors Commentary
✅ Purchase Order 3 $177K+ (Mernova Cannabis)
🔲 Purchase Order 4 (Mernova Cannabis)
🔲 Purchase Order 5 (Mernova Cannabis)
🔲 Purchase Order 6 (Mernova Cannabis)
🔲 Purchase Order 7 (Mernova Cannabis)
🔲 Purchase Order 8 (Mernova Cannabis)

Psychedelics

✅ Plan to acquire Halucenex (psychedlics company) announced: Next Investors Commentary
✅ Increase Psilocybin Supply for Clinical Trials: Next Investors Commentary
🔲 Halucenex receives Dealers License
🔲 Complete Halucenex Acquisition
🔲 Phase II Clinical Trials recruitment
🔲 Phase II Clinical Trials begin
🔲 Phase II Clinical Trials - interim results
🔲 Phase II Clinical Trial Completed
🔲 Phase II Clinical Trial Results
🔲 Commercialisation milestone

Investment Plan

ASX:CPH is a medium term investment we hold and write about that is not currently in the portfolio. We took a position at 3c in October 2020 as a short term hold which upgraded to a medium hold after the company delivered. On March 26 2021 we increased our position at 19c. We are considering adding CPH to our long term portfolio if it can deliver a few more key milestones.

✅ Initial Investment @ 3c
✅ Increased Investment 19c
🔲 Increased Investment
✅ Price Increase 500% from Initial Entry
✅ Price Increase 1,000% from Initial Entry
🔲 Price Increase 2,000% from Initial Entry
🔲 12 Month Capital Gains Discount
✅ Free Carry
✅ Take Profits
🔲 Hold Remaining Position for Two Years